Wilson K M, Fregly M J
Peptides. 1985 Jul-Aug;6(4):695-701. doi: 10.1016/0196-9781(85)90174-3.
Systemic administration of angiotensin II (AII) to the rat has previously been shown to induce a dose-dependent, hypothermic response manifested by a fall in colonic temperature (CT), a decrease in heat production and an increase in tail skin temperature (TST). The factors mediating AII-induced hypothermia and their site of action were the subjects of the present investigation. To this end, intracerebroventricular administration of 1 microgram of AII induced a 0.4 degrees C reduction in CT and a 2.4 degrees C increase in TST. In contrast, SC administration of 200 micrograms angiotensin III/kg induced a slight increase in CT but had no affect on TST. Pretreatment with the AII-receptor antagonist, saralasin, at either 1 or 10 micrograms/kg, SC did not affect either the fall in CT or the increase in TST induced by administration of 200 micrograms AII/kg, SC. However, the administration of 100 micrograms saralasin/kg, SC attenuated both the fall in CT and the increase in TST induced by either 100 or 200 micrograms AII/kg. Since both the presynaptic alpha adrenoceptor agonist, clonidine, and the opioid antagonist, naloxone, modulate the pressor and dipsogenic responses to AII, their effects on AII-induced hypothermia were tested. Both clonidine (25 micrograms/kg, SC) and naloxone (1 mg/kg, IP) enhanced the fall in CT. Clonidine lengthened the duration of the increase in TST while naloxone had no effect. Pretreatment with the presynaptic adrenoceptor antagonist, yohimbine (300 micrograms/kg, SC), did not alter the hypothermic response to administration of AII. To determine whether vasodilation of the tail of the rat was mediated by AII-induced prostaglandin release, indomethacin (4 and 6 mg/kg) was administered.(ABSTRACT TRUNCATED AT 250 WORDS)
先前已表明,对大鼠进行血管紧张素II(AII)的全身给药会诱导剂量依赖性的体温过低反应,表现为结肠温度(CT)下降、产热减少以及尾皮温度(TST)升高。介导AII诱导的体温过低的因素及其作用部位是本研究的主题。为此,脑室内注射1微克AII可使CT降低0.4摄氏度,TST升高2.4摄氏度。相比之下,皮下注射200微克血管紧张素III/千克可使CT略有升高,但对TST无影响。以1或10微克/千克的剂量皮下注射AII受体拮抗剂沙拉新进行预处理,对皮下注射200微克AII/千克所诱导的CT下降或TST升高均无影响。然而,皮下注射100微克沙拉新/千克可减弱由100或200微克AII/千克所诱导的CT下降和TST升高。由于突触前α肾上腺素能受体激动剂可乐定和阿片类拮抗剂纳洛酮均可调节对AII的升压和致渴反应,因此测试了它们对AII诱导的体温过低的影响。可乐定(25微克/千克,皮下注射)和纳洛酮(1毫克/千克,腹腔注射)均增强了CT的下降。可乐定延长了TST升高的持续时间,而纳洛酮则无此作用。用突触前肾上腺素能受体拮抗剂育亨宾(300微克/千克,皮下注射)进行预处理,并未改变对AII给药的体温过低反应。为了确定大鼠尾部的血管舒张是否由AII诱导的前列腺素释放介导,给予了吲哚美辛(4和6毫克/千克)。(摘要截短于250字)